Inhibition of salivary secretion by lipopolysaccharide: possible role of prostaglandins

Citation
A. Lomniczi et al., Inhibition of salivary secretion by lipopolysaccharide: possible role of prostaglandins, AM J P-ENDO, 281(2), 2001, pp. E405-E411
Citations number
22
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
ISSN journal
01931849 → ACNP
Volume
281
Issue
2
Year of publication
2001
Pages
E405 - E411
Database
ISI
SICI code
0193-1849(200108)281:2<E405:IOSSBL>2.0.ZU;2-#
Abstract
Inducible (calcium-independent) nitric oxide synthase (iNOS) and cyclooxyge nase-2 (COX-2) are important in the regulation of the function of different organs during infection. A single dose of lipopolysaccharide (LPS; 5 mg/kg ip) within 6 h increased NOS activity (20%) and prostaglandin E (PGE) cont ent (100%) in submandibular glands (SMG) and blocked stimulated salivary se cretion in adult male rats. The administration of an iNOS synthesis inhibit or, aminoguanidine (AG), with LPS decreased NOS activity and PGE content. F urthermore, the administration of meloxicam (MLX), an inhibitor of COX-2, b locked the increase in PGE and the production of NO. The incubation of slic es of SMG in the presence of 3-morpholinosydnonimine, a donor of NO, increa sed the release of PGE highly significantly. The incubation of SMG in the p resence of a PGE(1) analog (alprostadil) increased the production of NO. Th ese results indicate that LPS activates NOS, leading to NO release, which a ctivates COX, generating PGEs that act back to further activate NOS, causin g further generation of PGEs by activation of COX. Because the alprostadil administration inhibited stimulated salivation, LPS-induced inhibition of s alivation appears to be caused by increased PGE production. Diminished sali vary secretion produces poor oral health; thus the use of COX-2 inhibitors to counteract the effects of inhibited salivation should be considered.